Tia
PrivateLast Round
Series D
May 17, 2026
Est. Valuation
$600M
Total Funding Raised
$130.78M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tia operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series D round in May 2026.
Tia is a health technology company that provides a modern medical home for women, integrating primary care, gynecology, mental health, and wellness services into a single, coordinated care model.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Mental Health, Patient Engagement, Medical AI
Business Model
B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tia Comparables
Compare Tia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Advantia Health | 82% | |
| Diana Health | 74% | |
| Maven Clinic | 73% |
For institutional investors. Book with your work email.
Tia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 17, 2026 | ||||
| Series B Extension | Mar 7, 2023 | ||||
| Series B | Sep 14, 2021 | ||||
| Series A | Mar 17, 2020 | ||||
| Seed | Sep 24, 2017 | ||||
Pre Seed | May 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Torch Capital | Series B, Series A |
| Define Ventures | Series B, Seed, Series A |
| Threshold Ventures | Series B, Series A |
| Human Ventures | Series B |
| Pivotal Ventures | Series B Extension |
| Combine | Series B, Seed |
| GingerBread Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 39% MoM.
- May 17, 2026
Completed a Series D funding round.
For institutional investors. Book with your work email.
Tia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tia's valuation, stock price, and market status.
Is Tia a public or private company?
Tia is a private company.
What is the current stock price of Tia?
Tia is a private company, so its shares have no public market price. Caplight tracks Tia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tia worth (valuation)?
Tia's valuation is estimated at $600.0M based on funding round data.
Can I buy Tia stock?
Tia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tia's last funding round?
Tia's most recent funding round was Series D on May 17, 2026.
Who are the main investors in Tia?
Key investors in Tia include Threshold Ventures, Lone Pine Capital, Pivotal Ventures.
Will Tia IPO soon?
No public IPO plans have been announced for Tia.
How can I track Tia secondary market activity?
Caplight tracks bids, offers, and trades in Tia's shares on secondary markets.